In addition, FOXP1 is reported to be an estrogen-inducible and androgen-inducible transcription factor (Shigekawa et al, 2011; Takayama et al, 2008)—a factor that may be correlated with its oncogenic function in hormone-sensitive breast cancer, ovarian cancer, and prostate cancer. This evidence concerns the gene FOXP1 and prostate carcinoma.